期刊文献+

61株甲源性近平滑念珠菌药敏试验报告 被引量:1

暂未订购
导出
摘要 根据美国国家临床实验室标准化委员会M27-A微量稀释法对近平滑念珠菌作了伊曲康唑、特比萘芬和氟康唑3种抗真菌药物敏感性测定。结果:伊曲康唑、特比萘芬、氟康唑对61株近平滑念珠菌的平均MIC值分别为:3.20μg/mL、0.42μg/mL、2.33μg/mL。体外特比萘芬对近平滑念珠菌敏感性高于伊曲康唑和氟康唑。
出处 《中国麻风皮肤病杂志》 2006年第1期44-45,共2页 China Journal of Leprosy and Skin Diseases
基金 杭州市卫生局2001年科技A类计划(01A026)
  • 相关文献

参考文献8

  • 1Segal R, Kimchi A, Kritzman A, et al. The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel.Mycoses 2000,43:349 - 353.
  • 2Segal R, Kritzman A, Cividalli L. Treatment of Candida nail infection with terbinafine. J Am Acad Dermatol 1996,35:958-961.
  • 3Gupta AK, Shear NH. A risk - benefit assessment of the newer oral antifungal agents used to treat onychomycosis. Drug Saf 2000,22: 33- 52.
  • 4National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptilibity testing of yeasts:approved standard. NCCLS document M27 - A. Wayne, Pennsylavania NCCLS 1997.
  • 5Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003,148:402 - 410.
  • 6Gupta AK, Shear NJ. The new oral antifungal agents for onychomycosis of the toenail. J Eur Acad Dermatol Venereol 1999,13-1 -3.
  • 7Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involument by non - dermatophytic fungi. Br J Dennatol 1994,130:43 : 16 - 21.
  • 8Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother 1998,42:1057- 1061.

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部